跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Fromefen
Approved
STANDARD
Fromefen
New Myrex Laboratories, Inc.
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
6387231c565a2fd8
Company
New Myrex Laboratories, Inc.
Type
Standard
Approval Details
Approval Id
6387231c565a2fd8
Drug Approval Philippines Name
Fromefen
Product Name
Fromefen
Registration Number
DRP-681-01
Brand Name
Fromefen
Generic Name
Mefenamic Acid
Dosage Form
Capsule
Dosage Strength
500mg
Manufacturer
New Myrex Laboratories, Inc.
Distributor
Brymar Pharmaceuticals
Issuance Date
29 November 2022
Expiry Date
11 December 2027
Pharmacologic Category
Non-Steroidal Anti-Inflammatory Drug (NSAID)
Classification
Prescription Drug (RX)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
6387231c565a2fd8
Type
Standard
Back to Philippines FDA Approvals
Fromefen - Philippines FDA Drug Approval Details